BGMS Earnings Bio Green Med Solution, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–27 of 27
| Q4 2025 (derived) | 2025-12-31 | -4.16 | 2026-03-30 | 10-K |
| FY 2025 | 2025-12-31 | -6.45 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -1.31 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.98 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | 0.00 | 2025-05-14 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -284.21 | 2025-04-02 | 10-K |
| FY 2024 | 2024-12-31 | -502.46 | 2025-04-02 | 10-K |
| Q3 2024 | 2024-09-30 | -43.80 | — | — |
| Q2 2024 | 2024-06-30 | -172.18 | — | — |
| Q1 2024 | 2024-03-31 | -2.27 | 2024-05-14 | 10-Q |
| FY 2023 | 2023-12-31 | -26.75 | — | — |
| Q2 2023 | 2023-06-30 | -0.44 | 2023-08-10 | 10-Q |
| Q1 2023 | 2023-03-31 | -7.00 | 2023-05-11 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -20.06 | 2023-03-08 | 10-K |
| FY 2022 | 2022-12-31 | -27.24 | 2023-03-08 | 10-K |
| Q3 2022 | 2022-09-30 | -0.42 | 2022-11-10 | 10-Q |
| Q2 2022 | 2022-06-30 | -0.46 | 2022-08-11 | 10-Q |
| Q1 2022 | 2022-03-31 | -6.30 | 2022-05-12 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 6.46 | 2022-03-30 | 10-K |
| FY 2021 | 2021-12-31 | -2.14 | 2022-03-30 | 10-K |
| Q3 2021 | 2021-09-30 | -0.54 | — | — |
| Q2 2021 | 2021-06-30 | -0.56 | — | — |
| Q1 2021 | 2021-03-31 | -7.50 | — | — |
| FY 2020 | 2020-12-31 | -3.42 | — | — |
| Q2 2014 | 2014-06-30 | -0.22 | 2014-08-12 | 10-Q |
| Q2 2013 | 2013-06-30 | 0.10 | 2013-08-14 | 10-Q |
| Q2 2012 | 2012-06-30 | -0.45 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.